Home

Market Capitalization of Sharon Bio-medicine Ltd

Image

Sharon Bio-Medicine Ltd

NSE: SHARONBIO

Market Cap

₹ 38.18 crore

Last updated on: Mar 28, 2025

Key Highlights

  • The Market Cap of Sharon Bio-Medicine Ltd is ₹ 38.18 crore as of 28 Mar 19 .
  • The Latest Trading Price of Sharon Bio-Medicine Ltd is ₹ 3.21 as of 28 Mar 15:30 .
  • The Dividend Payouts of Sharon Bio-Medicine Ltd is ₹ 0.36 as of Dec 11, 2014 .
Image

Sharon Bio-Medicine Ltd

NSE: SHARONBIO

Share Price

₹ 3.21

-0.05 (-1.53%)

stock direction

Last updated on: Mar 28, 2025

Market Price of Sharon Bio-Medicine Ltd

1M

1Y

3Y

5Y

Monitoring Sharon Bio-Medicine Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Mar 20193.21
27 Mar 20193.26
26 Mar 20193.43
25 Mar 20193.61
22 Mar 20193.79
20 Mar 20193.98
19 Mar 20194.17
18 Mar 20194.37
15 Mar 20194.43
14 Mar 20194.22

BlinkX Score for Sharon Bio-Medicine Ltd

Asset Value vs Market Value of Sharon Bio-Medicine Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Sharon Bio-Medicine Ltd

No data available

No data available

Historical P/E Ratio of Sharon Bio-Medicine Ltd

No data available

* All values are in %

Historical Revenue of Sharon Bio-Medicine Ltd

No data available

* All values are in crore

Historical EBITDA of Sharon Bio-Medicine Ltd

No data available

* All values are in crore

Historical Net Profit of Sharon Bio-Medicine Ltd

No data available

* All values are in crore

Image

Sharon Bio-Medicine Ltd

NSE: SHARONBIO

DIVIDENDPAYOUT

₹ -

Last updated on: Dec 11, 2025

About Sharon Bio-Medicine Ltd

  • Incorporated in 1989,Sharon Bio-Medicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient (API), intermediates and formulations.
  • During the fiscal year ended June 30, 2010, it had set up an active pharmaceutical ingredients plant in Taloja near Navi Mumbai.The company had installed capacity of 150,000 liters of reactors capacity of API and intermediates, and 2.5 billion tablets per shift per annum and one billion capsules per shift per annum.
  • Its products include Trimetazidine Di Hydrochloride, Ketoconzole, Pentaprazole, Amlodipine Besylate, Atomoxetine Hcl, Carisoprodl, Closantel Base, Glimepiride, Ketoconazole, Nifedipibe, Racecadotril, Toldimfos, Telmisartan, Tamsulosin, Itraconazole, Mesalazine, Lansoprazole and Doxorubicin Inj.

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for null Market Cap

What is the market cap of Sharon Bio-Medicine Ltd?

As of May 11, 2025, Sharon Bio-Medicine Ltd has a market capitalization of ₹38.18, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Sharon Bio-Medicine Ltd's market capitalization?

Sharon Bio-Medicine Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Sharon Bio-Medicine Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Sharon Bio-Medicine Ltd's market capitalization change?

Sharon Bio-Medicine Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions